Long-chain n-3 (v-3) polyunsaturated fatty acids exert beneficial effects in neuroendocrine dysfunctions in animal models and clinical trials. However, the mechanism(s) underlying the beneficial effects remains to be elucidated. We hypothesized that dietary treatment with fish oil (FO) could mitigate LPS-induced activation of the hypothalamic-pituitary-adrenal (HPA) axis through inhibition of Toll-like receptor 4 and nucleotide-binding oligomerization domain protein signaling pathways. Twentyfour weaned pigs were used in a 2 3 2 factorial design, and the main factors consisted of diet (5% corn oil vs. 5% FO) and immunological challenge (saline vs. LPS). After 21 d of dietary treatment with 5% corn oil or FO diets, pigs were treated with saline or LPS. Blood samples were collected at 0 (preinjection), 2, and 4 h postinjection, and then pigs were humanely killed by intravenous injection of 40 mg/kg body weight sodium pentobarbital for tissue sample collection. FO led to enrichment of eicosapentaenoic acid and docosahexaenoic acid and total n-3 polyunsaturated fatty acids in hypothalamus, pituitary gland, adrenal gland, spleen, and thymus. FO decreased plasma adrenocorticotrophin and cortisol concentrations as well as mRNA expressions of hypothalamic corticotropin releasing hormone and pituitary proopiomelanocortin. FO also reduced mRNA expression of tumor necrosis factor-a in hypothalamus, adrenal gland, spleen, and thymus, and of cyclooxygenase 2 in hypothalamus. Moreover, FO downregulated the mRNA expressions of Toll-like receptor 4 (TLR4) and its downstream molecules, including cluster differentiation factor 14, myeloid differentiation factor 2, myeloid differentiation factor 88, interleukin-1 receptor-associated kinase 1, tumor necrosis factor-a receptor-associated factor 6, and nuclear factor kappa-light-chainenhancer of activated B cells p65, and also decreased the mRNA expressions of nucleotide-binding oligomerization domain 1, nucleotide-binding oligomerization domain 2, and their adaptor molecule receptor-interacting serine/threonine-protein kinase 2.
Introduction
The immune and neuroendocrine systems extensively communicate with each other when the body is under stress or infection (1) . An immunological challenge involves the production of a great variety of proinflammatory cytokines, such as IL-1b, IL-6, and TNF-a (2). Proinflammatory cytokines have been shown to regulate central nervous system function and contribute to many changes in psychiatric disorders and neurodegenerative diseases (3) . In the neuroendocrine-immune network, the hypothalamic-pituitary-adrenal (HPA) 6 axis plays a critical role in stress or infection (4) . Research has shown that these proinflammatory cytokines participate as mediators of the HPA axis and the rise of these proinflammatory cytokines results in activation of the HPA axis, thereby adding to the stress response (1, 5) . Thus, nutritional interventions that reduce the release of these proinflammatory cytokines may be beneficial in mitigating negative neuroendocrine and immunological effects induced by immunological challenge (6) . Long-chain n-3 PUFAs, including EPA (20:5n-3) and DHA (22:6n-3), which are abundant in deep sea fish, have been used as immune modulators (7) (8) (9) . Accumulating literature has demonstrated that n-3 PUFAs play beneficial roles in inflammation and inflammatory diseases (7) . The beneficial role of n-3 PUFAs may be associated with their inhibitory effects on the overproduction of proinflammatory mediators such as proinflammatory cytokines (10, 11) . In addition, n-3 PUFAs have been found to play an important role in neuroendocrine dysfunctions (12, 13) , neurodegenerative diseases such as Alzheimer disease and Parkinson disease (14) , and neuropsychiatric disorders such as depression and anxiety (15, 16) . Ross (16) reported that supplementation with n-3 PUFAs inhibited activation of the HPA axis and ameliorated some of the symptoms of anxiety. However, the mechanism(s) underlying the protective role of n-3 PUFAs on neuroendocrine disorder remains to be elucidated.
Pattern recognition receptors, such as transmembrane Tolllike receptors (TLRs) and cytoplasmic nucleotide-binding oligomerization domain proteins (NODs), play important roles in detecting microbial invasion and activating the innate immune system by recognition of pathogen-associated molecular patterns (PAMPs) (17, 18) . Interaction of TLRs or NODs with their specific PAMPs leads to the induction of NF-kB activation via a series of downstream signals (17) . Activated NF-kB provokes production of proinflammatory cytokines, including IL-1b, IL-6, and TNF-a (17) . Consequently, these cytokines mediate the hostÕs defense against invading pathogens but also can result in collateral host-tissue damage and neuroendocrine disorders. Currently, research has shown that pattern recognition receptors are involved in immune-adrenal crosstalk (19, 20) .
Because significant interactions occur between the immune and neuroendocrine systems under stress or infection (4), we hypothesized that dietary n-3 PUFA supplementation might affect the HPA axis by modulating the production of proinflammatory cytokines in the HPA axis and immune system via regulating TLR4 and NOD signaling pathways. In our current study, Escherichia coli LPS was administered as an inflammatory agent to induce immunological challenge following the model of Liu et al. (6) . In addition, we used a piglet model, an excellent animal model for human nutrition and physiology (21, 22) . Our aim was to investigate whether dietary treatment of fish oil (FO) (abundant in n-3 PUFAs, especially EPA and DHA) could mitigate LPS-induced activation of HPA axis and regulate TLR4 and NOD signaling pathways.
Materials and Methods
Experimental animals and design. All procedures for this experiment were approved by the Animal Care and Use Committee of Hubei Province, China. Experimental animals, design, and procedures were the same as described previously (23) . Briefly, 24 weaned barrows [9.0 6 0.7 kg initial body weight (BW)] were randomly divided into 4 treatment groups. The trial was arranged in a 2 3 2 factorial design that included diet (5% corn oil vs. 5% FO) and immunological challenge (saline vs. LPS). Ingredient composition and fatty acid profiles of 5% corn oil or FO diets were reported previously (23). After 21 d of feeding 5% corn oil or FO diets, the challenged group received an intraperitoneal injection with E. coli LPS (E. coli serotype 055: B5, Sigma Chemical) at 100 mg/kg BW and the unchallenged group received an equivalent amount of sterile saline. The dose of LPS (100 mg/kg BW) was chosen according to our previous studies (6, 24, 25) , which showed that this dose of LPS caused activation of the HPA axis (6, 25) and increased expression of proinflammatory cytokines in the HPA axis (6) and immune tissues (24) of weaned pigs.
Blood and tissue sample collections. At preinjection (0 h), 2, and 4 h postinjection, blood samples were harvested into 10-mL heparinized vacuum tubes (Becton Dickinson Vacutainer System) and centrifuged (3500 3 g for 10 min) to collect plasma. Plasma from each pig was stored at -80°C until further analysis. After blood collection at 4 h, all pigs were humanely killed. The hypothalamus, pituitary gland, adrenal gland, thymus, and spleen were collected, frozen immediately in liquid nitrogen, and then stored at 280°C until analysis of mRNA abundance and fatty acid profiles. Many studies have shown that, within 1-6 h postinjection, LPS activated the HPA axis and increased proinflammatory cytokine production in mice, rats, and pigs (6, 13, 26, 27) . Thus, we used the time point of 2 or 4 h after LPS or saline treatment for experimental measurements in plasma or tissues.
Fatty acid analysis of tissues. The fatty acid composition of total fat in the tissues was assayed in accordance with Nieto et al. (28) .
Measurement of plasma corticotropin releasing hormone , adrenocorticotrophin, and cortisol. Plasma corticotropin releasing hormone (CRH), adrenocorticotrophin (ACTH), and cortisol concentrations were assayed according to the procedures of Liu et al. (6, 25) . mRNA expression analysis. Total RNA extraction, quantification, reverse transcription, and real-time PCR (specific primer sequences were used; Supplemental Table 1 ) were conducted as previously described (23) . The expression of the target genes relative to the housekeeping gene (GADPH) was analyzed by the 2 -DDCT method (29) . GADPH did not display any difference among 4 treatment groups. Relative mRNA expression of each target gene was normalized to the pigs fed a 5% corn oil-supplemented diet and treated with sterile saline solution.
Statistical analysis. Statistical analysis was performed by ANOVA using the general linear model procedure of Statistical Analysis System (SAS Institute) appropriate for a factorial arrangement of treatments. The statistical model consisted of the effects of diet (corn oil vs. FO), challenge (saline vs. LPS), and their interactions. Data were expressed as means 6 SEs. When significant diet 3 LPS interaction or a trend for diet 3 LPS interaction occurred, post hoc testing was performed using BonferroniÕs multiple comparison tests. Differences were considered as significant when P # 0.05. Instances in which 0.05 < P < 0.10 are discussed as trends.
Results
Tissue fatty acid composition 4 h after LPS challenge. Fatty acid composition of tissues ( Table 1 ) mostly reflected the dietary fatty acid composition, which was reported previously (23) . Fish oil exerted a similar effect on fatty acid profiles in hypothalamus, pituitary gland, adrenal gland, spleen, and thymus. In general, relative to pigs receiving the corn oil diet, pigs receiving the FO diet showed higher proportions of palmitoleic acid (16:1n-7), EPA, DHA, and total n-3 PUFAs, and showed lower proportions of linoleic acid (18:2n-6), arachidonic acid (20:4n-6), total n-6 PUFAs, and the ratio of n-6 to n-3 PUFAs in the tissues (P < 0.05).
Plasma CRH, ACTH, and cortisol concentrations before (0 h), 2 and 4 h after LPS challenge. LPS challenge induced fever, anorexia, inactivity, and shivering within 1 h in all pigs (data not shown). Plasma TNF-a concentration was reported previously (30) and is presented here for reference ( Table 2) . There was no difference in plasma variables among 4 treatments at 0 h (prechallenge) ( Table 2 ). The pigs injected with LPS had higher concentrations of plasma TNF-a, ACTH, and cortisol at 2 h postinjection (P < 0.01), and TNF-a and cortisol at 4 h postinjection (P < 0.05). A diet 3 LPS interaction occurred for TNF-a (P = 0.06) and cortisol (P = 0.001) at 2 h postinjection, and TNF-a (P < 0.05) at 4 h postinjection. The responses of these variables to LPS treatment were lower in pigs fed the diet with FO than the diet with corn oil. For pigs injected with saline, diet did not affect these variables. No diet 3 LPS interaction was observed for ACTH at 2 h postinjection and for ACTH and cortisol at 4 h postinjection. However, the pigs receiving the FO diet displayed lower ACTH concentration at 2 and 4 h postinjection (P < 0.05) compared with pigs receiving the corn oil diet. Neither diet nor LPS affected plasma CRH concentration.
mRNA abundance of hypothalamic CRH, pituitary CRH receptor 1 and proopiomelanocortin, and adrenal type II melanocortin receptor and steroidogenic acute regulatory protein 4 h after LPS challenge. Relative to pigs treated with saline, the pigs injected with LPS displayed higher mRNA abundance of hypothalamic CRH, pituitary proopiomelanocortin (POMC), and adrenal steroidogenic acute regulatory protein (StAR) (P < 0.001) ( Table 3) . A diet 3 LPS interaction (P < 0.05) was found for hypothalamic CRH and pituitary POMC. The responses of these variables to LPS treatment were lower in pigs fed the diet with FO than in pigs fed the diet with corn oil. For pigs treated with saline, diet did not affect these variables. No diet 3 LPS interaction occurred for pituitary CRH receptor 1 (CRHR1). Pigs treated with LPS exhibited lower mRNA abundance of pituitary CRHR1 compared with pigs treated with sterile saline (P < 0.01). However, the pigs receiving the FO diet displayed a higher pituitary CRHR1 mRNA abundance than pigs receiving the corn oil diet (P < 0.001). Neither diet nor LPS 1 Values are means 6 SEs, n = 6 (1 pig/pen). Labeled means in a row without a common letter differ, P , 0.05. The detection limit was 0.001 mg/g diet for each fatty acid. ND, not detectable. 2 The fatty acid composition from 4:0 to 24:1n-9 were measured duplicately. Only the major fatty acids are shown. 3 Total n-6 PUFAs and total n-3 PUFAs were equal to the sum of all the n-6 or n-3 PUFAs assayed. mRNA abundance of TLR4 and NODs and their downstream signals 4 h after LPS challenge. Compared with the saline-treated pigs, the LPS-treated pigs displayed higher mRNA abundance of hypothalamic TLR4, cluster differentiation factor 14 (CD14), myeloid differentiation factor 2 (MD2), myeloid differentiation factor 88 (MyD88), interleukin-1 receptorassociated kinase 1 (IRAK1), tumor necrosis factor (TNF)-a receptor-associated factor 6 (TRAF6), NOD1, receptorinteracting serine/threonine-protein kinase 2 (RIPK2), nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) p65, TNF-a, and cyclooxygenase 2 (COX2) (P < 0.05) ( Table 3) . There was a diet 3 LPS interaction found for hypothalamic CD14, TRAF6, and COX2 (P < 0.05). The responses of these variables to LPS were lower in pigs fed FO than in pigs fed corn oil. For pigs injected with saline, diet had no effect on this variable. No diet 3 LPS interaction was found for hypothalamic IRAK1, NOD1, and TNF-a. However, the pigs receiving FO displayed lower hypothalamic mRNA abundance of IRAK1 and NOD1 (P < 0.05) and tended to display lower TNF-a mRNA abundance (P < 0.10) relative to the pigs fed corn oil. Neither diet nor LPS affected hypothalamic NOD2 mRNA abundance. Pigs treated with LPS displayed higher mRNA abundance of pituitary TLR4, CD14, MD2, MyD88, IRAK1, TRAF6, NOD1, NOD2, RIPK2, NF-kB p65, TNF-a, and COX2 than pigs treated with saline (P < 0.05) ( Table 3) . A diet 3 LPS interaction was found for pituitary TLR4, CD14, IRAK1, and TRAF6 (P < 0.05). The responses of these variables to LPS treatment were lower in pigs fed FO than in pigs fed corn oil. For pigs injected with saline, diet did not affect these variables.
Pigs challenge with LPS displayed higher mRNA abundance of TLR4, CD14, MD2, MyD88, IRAK1, TRAF6, NOD1, NOD2, RIPK2, NF-kB p65, TNF-a, and COX2 in adrenal gland compared with pigs injected with saline (P < 0.001) ( Table  3) . A diet 3 LPS interaction was observed for adrenal TLR4, CD14, MyD88, NOD2, and TNF-a (P # 0.05). The responses of these variables to LPS treatment were lower in pigs fed FO than in pigs fed corn oil. For pigs injected with saline, diet had no effect on these variables. No diet 3 LPS interaction occurred for adrenal MD2, IRAK1, RIPK2, and NF-kB p65. However, the pigs receiving the FO diet had lower MD2 mRNA abundance (P < 0.05) and tended to have lower IRAK1, RIPK2, and NF-kB p65 mRNA abundance (P < 0.10) relative to pigs fed the corn oil diet.
Pigs challenged with LPS displayed higher mRNA abundance of TLR4, CD14, MyD88, IRAK1, TRAF6, NOD1, NOD2, RIPK2, NF-kB p65, TNF-a, and COX2 in spleen relative to pigs treated with saline (P < 0.05) ( Table 3) . A diet 3 LPS interaction was observed for splenic TLR4, CD14, and NOD1 (P < 0.01). A trend for interaction was observed for splenic MyD88, TRAF6, and TNF-a (P < 0.10). The responses of these variables to LPS treatment were lower in pigs fed FO than pigs fed corn oil. For pigs injected with saline, diet had no effect on these variables. No diet 3 LPS interaction was found for spleen IRAK1. However, the pigs receiving FO displayed lower adrenal IRAK1 mRNA abundance (P = 0.05) than pigs receiving corn oil. Neither diet nor LPS affected spleen MD2 mRNA abundance.
Pigs treated with LPS displayed higher mRNA abundance of thymic TLR4, CD14, NOD2, TNF-a, and COX2 compared with pigs treated with saline (P < 0.05) ( Table 3 ). There was a diet 3 LPS interaction observed for thymic CD14 and RIPK2 (P < 0.05). The responses of this variable to LPS treatment were lower in pigs fed FO than in pigs fed corn oil. For pigs injected with saline, diet had no effect on this variable. No diet 3 LPS interaction occurred for thymic TLR4, IRAK1, TRAF6, and TNF-a. However, the pigs receiving FO diet displayed lower TLR4, TRAF6, and TNF-a mRNA abundance (P < 0.05) and tended to display lower thymic IRAK1 mRNA abundance (P < 0.10) compared with pigs receiving corn oil diet. Neither diet nor LPS affected thymic mRNA abundance of MD2, MyD88, NOD1, and NF-kB p65.
Discussion
Our previous studies demonstrated that dietary supplementation with 5% FO alleviated LPS-induced inflammation in intestine and muscle and enhanced intestinal integrity and muscle protein mass in a weaned piglet model (23, 30) . We extended our current experiment into the HPA axis and immune tissues to investigate the effect of 5% FO on the HPA axis after LPS treatment using the same animals. Similar to the results of fatty acid composition of total fat in intestine and muscle (23, 30) , EPA, DHA, and total n-3 PUFAs were enriched in total fat of hypothalamus, pituitary gland, adrenal gland, spleen, and thymus through 5% FO treatment. In addition, Moranis et al. (31) also reported that n-3 PUFA supplementation increased DHA proportion and decreased arachidonic acid proportion in phospholipids of cortex and liver in adult and aged mice. In this study, LPS challenge increased plasma ACTH and cortisol concentrations as well as mRNA abundance of hypothalamic CRH, pituitary POMC (ACTH precursor peptide), and adrenal StAR (rate-limiting enzyme involved in steroidogenesis), which indicated that LPS challenge activated HPA axis. FO supplementation alleviated the increase of plasma ACTH and cortisol concentrations, and of mRNA abundances of hypothalamic CRH and pituitary POMC, indicating that FO was effective in alleviating the activation of the HPA axis. Similarly, our previous study showed that FO supplementation alleviated the increase of plasma cortisol concentration caused by LPS challenge in weaned pigs compared with corn oil (10) . In addition, Michaeli et al. (13) showed that oral FO supplementation significantly attenuated fever and the increase of plasma ACTH and cortisol concentrations induced by LPS challenge in healthy volunteers.
We hypothesized that FO would alleviate activation of the HPA axis by attenuating the inflammatory response in the HPA axis and immune system after LPS challenge. Minimal peripheral LPS can cross the blood-brain barrier (32) , thus peripherally administrated LPS induces brain inflammatory response via indirect mechanisms (33) . In response to peripheral LPS challenge, a variety of cells in the immune system, such as activated macrophages, secrete high concentrations of proinflammatory cytokines (34, 35) . The proinflammatory cytokines emanating from the immune system can have profound effects on the neuroendocrine system, either by gaining direct access to the central nervous system (36, 37) or by triggering the synthesis of cytokines by cells in the central nervous system (38, 39) . These proinflammatory cytokines are chemical mediators that activate the HPA axis when the body is under stress or infection (4). In our study, consistent with activation of the HPA axis, LPS increased plasma TNF-a concentration and TNF-a mRNA expression in spleen and thymus as well as the hypothalamus and adrenal gland. Similarly, Erickson et al. (40) showed that 13 cytokine (e.g., TNF-a) and chemokine concentrations were increased in serum and brain after single and repeated peripheral injections of LPS. In the present study, consistent with alleviated activation of the HPA axis, FO supplementation attenuated the increase of plasma TNF-a concentration and TNF-a mRNA expression in the hypothalamus, adrenal gland, spleen, and thymus. Currently, there is a lot of research on the inhibitory effect of n-3 PUFAs on proinflammatory cytokines (7-9). The data are mainly focused on blood, immune cells or tissues, and intestines (7) (8) (9) . For example, our previous research showed that a 5% FO diet decreased TNF-a mRNA or protein concentration in intestine and muscle in piglets challenged with LPS compared with a 5% corn oil diet (23, 30) . However, the data exploring effects within the neuroendocrine system are limited. Liu (41) reported that supplementation of DHA in pregnant rats greatly decreased protein and mRNA expression of Tnf-a in brain tissues of fetal neonatal rats. In vitro, De Smedt-Peyrusse et al. (42) and Lu et al. (43) reported that DHA inhibited the production of proinflammatory cytokines by murine microglia. In our current study, it is possible that feeding pigs dietary FO alleviates the activation of the HPA axis partially by suppressing the production of brain or peripheral proinflammatory cytokines.
To explore the molecular mechanism(s) by which FO attenuated the activation of the HPA axis, we examined the role of the TLR4 signaling pathway. TLRs are an ancient conserved pattern recognition receptor family that recognizes PAMPs and plays a pivotal role in innate antibacterial and inflammatory responses (17, 18) . Among the TLR family, the best characterized member is TLR4, the receptor of LPS (17) . LPS is mainly recognized through the TLR4/MD2/CD14 complex (18) . When engaged by LPS, TLR4 transmits a signal that is passed onwards by a cascade of MyD88, IRAK1, and TRAF6 and finally triggers the activation of NF-kB (17) . Activated NFkB stimulates the expression of inflammatory genes, such as proinflammatory cytokines and COX2 (17) . In the present study, mRNA abundance of TLR4, CD14, MyD88, IRAK1, TRAF6, or NF-kB p65 in the HPA axis or immune tissues was decreased and the synthesis of TNF-a and mRNA abundance of COX2 were decreased simultaneously in pigs receiving FO diet after LPS treatment. So far, the research on n-3 PUFAs modulating TLR signaling in the neuroendocrine system is limited. Ibrahim et al. (44) reported that DHA led to a decreased TLR4 expression and a decreased production of IL-6, IL-8, and PGE 2 in IL-1b-induced intestinal microvascular endothelial cells. In addition, Wong et al. (45) demonstrated that lauric acid and LPS enhanced the association of TLR4, MyD88, and other signaling molecules into lipid rafts, resulting in the activation of the TLR4 signaling pathway and proinflammatory cytokine expression. However, DHA inhibited the effect of both lauric acid and LPS on promoting recruitment of these signaling proteins into lipid raft fractions, suggesting that DHA inhibited the TLR4 signaling pathway. Moreover, our previous study showed that FO inhibited TLR4 signaling in intestine and muscle in weaned piglets subjected to LPS treatment (23, 30) . In the present study, the inhibitory effect of FO on HPA axis activation might be associated with decreasing brain or peripheral proinflammatory cytokine production through downregulation of the TLR4 signaling pathway.
Besides TLRs, another family of pattern recognition receptors, cytoplasmic NODs, also play key roles in recognition of PAMPs and regulation of host innate immune response (17, 18) . The research on NOD has been mainly focused on NOD1 and NOD2. Similar to TLR4, NOD1 and NOD2 can also activate NF-kB via an adaptor molecule, RIPK2, resulting in transcriptional upregulation of proinflammatory cytokine genes (18) . In the current experiment, similar to TLR4 signaling pathway, we also found that mRNA abundance of hypothalamic and splenic NOD1, adrenal NOD2, adrenal and thymic RIPK2, and adrenal NF-kB p65 were decreased in pigs fed FO diet after LPS treatment. Until now, the research on n-3 PUFAs modulating NOD signaling in neuroendocrine system is limited. Zhao
Fish oil inhibits TLR4 and NOD signaling 1805 et al. (46) reported that saturated fatty acids (lauric acid) activated NF-kB and IL-8 expression in human colonic epithelial homozygous typing cells, but PUFAs, particularly n-3 PUFAs such as EPA or DHA, inhibited these effects by dominant negative forms of NOD1 or NOD2. In addition, our previous studies demonstrated that FO inhibited NOD2 signaling in intestine and muscle in weaned piglets after LPS challenge (23, 30 ). In the current study, it is possible the inhibitory effect of FO treatment on the activation of the HPA axis was also related to decreasing brain or peripheral proinflammatory cytokine expression through inhibition of the NOD signaling pathway.
In our experiment, tissue sample collection was conducted at only 1 time point (i.e., 4 h). This time point might not be the most appropriate to analyze all of proinflammatory mediators, neuroendocrine variables, and signaling molecules after LPS treatment because some variables were not changed greatly by LPS at this time point. In addition, protein expression of these variables were not determined because the samples of hypothalamus, pituitary gland, and adrenal gland were tiny. Because dynamic changes may occur in expression of tissue proinflammatory mediators, neuroendocrine variables, and signaling molecules (47) , tissue sample collections at more time points might be needed to confirm their roles in LPS-induced activation of the HPA axis, which awaits further experiments.
In conclusion, dietary FO treatment has beneficial effects in attenuating LPS-induced HPA axis activation. The beneficial effects of FO on the HPA axis may be associated with decreasing brain or peripheral proinflammatory cytokine expression through inhibiting TLR4 and NOD signaling pathways.
